Dr. Kei Hamazaki

 

Academic Degree(s)

MD, PhD

 

E-Mail

keihama@med.u-toyama.ac.jp

 

Current Position

Associate Professor, Department of Public Health, Faculty of Medicine, University of Toyama, Japan

Visiting scientist of National Institute of Mental Health, National Center of Neurology and Psychiatry, Japan

 

Professional Experience

Assistant Professor, Department of Public Health, Faculty of Medicine, University of Toyama, Japan (2008-2013)

Researcher in Division of Clinical Application, Department of Clinical Sciences, Institute of Natural Medicine in Toyama medical and pharmaceutical University, Japan (2004-2006)

Physician in Mie University Hospital, in Tsu National Hospital and in Mie Prefectural General Medical Center, Japan (1996-2000)

 

Education & Training

School of Medicine: Mie University, Japan (1990-1996)

Doctorate: Toyama Medical and Pharmaceutical University, Japan (2000-2004)

Post-Doctoral Training: NIH, USA (2006-2008)

 

Awards

2014, Mind-Body Interface International Symposium Mind-Body Interface International Symposium Overseas Travel Award

2009, The 79th Annual Meeting of the Japanese Society for Hygiene: Young Investigator’s Award

2008, NIH The 14th annual Fellows Award for Research Excellence (FARE) 2008 Investigator’s Award

 

Research Grants

Grant-in-aid for Scientific Research (C) (# 17K00849), 2017-2019

Grant-in-aid for Scientific Research (C) (# 25461726), 2013-2015

Grant-in-Aid for Young Scientists (B) (# 21790575), 2009-2012

The Tamura Foundation for Promotion of Science and Technology 2009-2010.

The Ichiro Kanehara foundation. 2011.

 

Committee & Membership

Director of Japan Society for Lipid Nutrition (2017-present)

Councilor of Japanese Society for Hygiene (2015-present)

A member of the International Society for the Study of Fatty Acids and Lipids

 

Selected Publication

  • Hamazaki K, et al. Fatty acid composition of the postmortem corpus callosum of patients with schizophrenia, bipolar disorder, or major depressive disorder. Eur Psychiat 2017;39:51-6
  • Hamazaki K, et al. Association of serum n-3 polyunsaturated fatty acids with psychological distress in the second and third trimesters of pregnancy: Adjunct Study of Japan Environment and Children's Study. Prostaglandins Leukot Essent Fatty Acids 2016;114:21-7
  • Hamazaki K, et al. Is vaccenic acid (18:1t n-7) associated with an increased incidence of hip fracture? An explanation for the calcium paradox. Prostaglandins Leukot Essent Fatty Acids 2016;109:2-8
  • Hamazaki K, et al. Fatty acid composition and fatty acid binding protein expression in the postmortem frontal cortex of patients with schizophrenia: A case-control study. Schizophr Res 2016;171(1-3):225-32
  • Hamazaki K, et al. Serum n-3 polyunsaturated fatty acids and psychological distress in early pregnancy: Adjunct case-control study of the Japan Environment & Children's Study. Transl Psychiatry 2016;6:e737
  • Hamazaki K, et al. Fish consumption and depressive symptoms in undergraduate students: a cross-sectional analysis. Eur Psychiat 2015;30(8):983-7
  • Hamazaki K, et al. Mead acid (20:3n-9) and n-3 polyunsaturated fatty acids are not associated with risk of posterior longitudinal ligament ossification: Results of a case-control study. Prostaglandins Leukot Essent Fatty Acids 2015; 96: 31-6
  • Hamazaki K, et al. Fatty acid composition of the postmortem prefrontal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder. Psychiatry Res 2015; 227: 353-9
  • Hamazaki K, et al. The role of high-density lipoprotein cholesterol in risk for posttraumatic stress disorder: Taking a nutritional approach toward universal prevention. Eur Psychiat 2014;29:408-13
  • Hamazaki K, et al. Abnormalities in the fatty acid composition of the postmortem entorhinal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder. Psychiatry Res 2013; 210:346-50